Hereditary Cancer tests in Dubai & UAE

Compare available Hereditary Cancer tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hereditary Cancer test prices

Showing 1–15 of 16 matching tests.

Hereditary Cancer diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1698 Featured Comprehensive Hereditary Cancer Panel (154 Genes) Test This test evaluates 154 genes for inherited mutations associated with an increased risk of hereditary cancers.	Peripheral Whole Blood	4–6 weeks	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants", "Insertions", "Deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting or special preparation is required"] Indications ["Individuals with a strong family history of cancer", "Individuals with multiple primary malignancies", "Individuals with early-onset tumors", "Individuals recommended by a specialist"] Measurement technique Confirm with laboratory Codes LOINC: 91847-5 ICD-10: Z15.01, Z15.02, Z15.03, Z15.04, Z15.09 Clinical summary This test evaluates 154 genes for inherited mutations associated with an increased risk of hereditary cancers.
TEST-2076 APC Gene Desmoid Disease Hereditary Genetic Test This test identifies pathogenic variants in the APC gene associated with hereditary desmoid disease and familial adenomatous polyposis (FAP).	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APC gene", "Hereditary predisposition to desmoid disease and FAP"] Parameters [] Preparation ["No fasting required", "Stay well-hydrated", "Bring Emirates ID and previous genetic reports"] Indications ["Personal or family history of desmoid tumours", "Personal or family history of FAP"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09, D48.1, M72.6 Clinical summary This test identifies pathogenic variants in the APC gene associated with hereditary desmoid disease and familial adenomatous polyposis (FAP).
TEST-1889 ARL11 Gene Tumor Predisposition Syndrome Test This test evaluates the ARL11 gene for pathogenic variants associated with an increased risk of hereditary cancer predisposition syndromes.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL11 gene", "Copy Number Variants (CNVs) in the ARL11 gene"] Parameters [{"name": "ARL11 Gene Variants", "reference_range": "No pathogenic or likely pathogenic variants detected"}, {"name": "Copy Number Variants (CNVs)", "reference_range": "No significant CNVs detected"}] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Individuals with a personal or family history suggestive of hereditary cancer predisposition syndromes linked to ARL11.", "Assessment of cancer risk in individuals with specific clinical features."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z15.09 Clinical summary This test evaluates the ARL11 gene for pathogenic variants associated with an increased risk of hereditary cancer predisposition syndromes.
TEST-2085 CDH1 Hereditary Diffuse Gastric Cancer (HDGC) Genetic Test This genetic test analyzes the CDH1 gene for pathogenic variants associated with Hereditary Diffuse Gastric Cancer (HDGC). It identifies mutations that increase the risk of develop...	Whole blood (EDTA), buccal swab, or FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic germline variants in the CDH1 gene", "Copy Number Variants (CNVs) within the CDH1 gene"] Parameters [] Preparation ["No fasting or dietary preparation required"] Indications ["Two or more cases of diffuse gastric cancer in first- or second-degree relatives", "One case of diffuse gastric cancer before age 40", "Personal or family history of diffuse gastric cancer and lobular breast cancer (one diagnosis before age 50)", "Known CDH1 mutation in a blood relative"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09 Clinical summary This genetic test analyzes the CDH1 gene for pathogenic variants associated with Hereditary Diffuse Gastric Cancer (HDGC). It identifies mutations that increase the risk of developing diffuse gastric cancer and lobular breast cancer.
TEST-2154 Colon Cancer Comprehensive Panel Genetic Test This test evaluates 33 genes associated with hereditary colorectal cancer syndromes using next-generation sequencing.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in 33 genes associated with hereditary colorectal cancer", "Genetic predisposition to Lynch syndrome and familial adenomatous polyposis"] Parameters [{"name": "Genes Analyzed", "reference_range": "APC, ATM, AXIN2, BLM, BMPR1A, BRCA1, BRCA2, CDH1, CDKN2A, CHEK2, EPCAM, FLCN, GALNT12, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, PRSS1, PTEN, RNF43, SMAD4, STK11, TGFBR2, TP53, VHL"}] Preparation ["Informed consent and genetic counseling session required", "Pedigree chart of affected relatives required"] Indications ["Individuals with a personal or family history suggestive of hereditary colorectal cancer syndromes", "Risk stratification for personalized cancer prevention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 81247-3 ICD-10: Z15.09, Z12.11 Clinical summary This test evaluates 33 genes associated with hereditary colorectal cancer syndromes using next-generation sequencing.
TEST-2126 MLH1 Gene (Hereditary Nonpolyposis Colorectal Cancer, Lynch Syndrome) Genetic Test This genetic test evaluates the MLH1 gene for mutations associated with an increased risk of hereditary nonpolyposis colorectal cancer (Lynch syndrome).	Whole Blood (EDTA), Extracted DNA, or FTA Card Specimen	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MLH1 gene mutations", "Germline variants"] Parameters [] Preparation ["No fasting required", "Anticoagulants may need temporary adjustment under medical supervision", "Provide complete family cancer history"] Indications ["Individuals with personal or family history suggestive of Lynch syndrome", "Risk assessment for hereditary colorectal cancer"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09, Z80.0 Clinical summary This genetic test evaluates the MLH1 gene for mutations associated with an increased risk of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
TEST-1980 MSH6 Gene (Mismatch Repair Cancer Syndrome) Genetic Test This test evaluates the MSH6 gene for mutations associated with Lynch Syndrome and increased cancer risk.	Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card Dried Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MSH6 gene mutations", "SNVs", "Indels", "CNVs"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any recent blood transfusions"] Indications ["Personal or family history suggestive of Lynch Syndrome", "Screening for hereditary cancer risk"] Measurement technique Confirm with laboratory Codes LOINC: 94122-9 ICD-10: Z15.09, Z80.49 Clinical summary This test evaluates the MSH6 gene for mutations associated with Lynch Syndrome and increased cancer risk.
TEST-1957 PALB2 Gene Pancreatic Cancer Susceptibility (Genetic Test) This test analyzes the PALB2 gene for pathogenic variants associated with increased risk of pancreatic, breast, and ovarian cancers.	Whole Blood (venous) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PALB2 gene", "Point mutations", "Insertions", "Deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Personal or family history of pancreatic, breast, or ovarian cancer", "Multiple first-degree relatives affected by these cancers", "Known PALB2 variant present in the family", "Comprehensive cancer risk assessment under genetic counseling guidance"] Measurement technique Confirm with laboratory Codes LOINC: 91787-7 ICD-10: Z15.09 Clinical summary This test analyzes the PALB2 gene for pathogenic variants associated with increased risk of pancreatic, breast, and ovarian cancers.
TEST-1954 PMS1 Gene Lynch Syndrome NGS Test This test detects pathogenic variants in the PMS1 gene associated with Lynch syndrome, an inherited condition increasing the risk of certain cancers.	Peripheral Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PMS1 gene", "Hereditary cancer susceptibility"] Parameters [] Preparation ["No fasting required", "Valid Emirates ID required for registration"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Assessment of hereditary cancer risk"] Measurement technique Confirm with laboratory Codes LOINC: 76918-9 ICD-10: Z15.09; Z80.0 Clinical summary This test detects pathogenic variants in the PMS1 gene associated with Lynch syndrome, an inherited condition increasing the risk of certain cancers.
TEST-2142 RAD51D Gene (Breast-Ovarian Cancer Susceptibility, Type 4) Genetic Test This test evaluates the RAD51D gene for pathogenic variants associated with hereditary breast and ovarian cancer susceptibility.	Peripheral whole blood or saliva (Oragene OG-500 kit)	3–4 weeks (fast-track available upon request)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RAD51D gene mutations", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Informed consent must be obtained prior to sample collection."] Indications ["Individuals aged 18 years and above with a personal or family history suggestive of hereditary breast and ovarian cancer syndrome."] Measurement technique Confirm with laboratory Codes LOINC: 94468-9 ICD-10: Z15.01, Z15.02 Clinical summary This test evaluates the RAD51D gene for pathogenic variants associated with hereditary breast and ovarian cancer susceptibility.
TEST-1984 RET Gene Multiple Endocrine Neoplasia Type 2A Genetic Test This test evaluates the entire RET proto-oncogene for germline mutations associated with Multiple Endocrine Neoplasia type 2A (MEN2A). It identifies genetic predisposition to medul...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the RET proto-oncogene", "Presence of pathogenic variants associated with MEN2A"] Parameters [] Preparation [] Indications ["Individuals with a family history of MEN2A", "Individuals with clinical features suggestive of MEN2A", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 21698-2 ICD-10: Z15.89 Clinical summary This test evaluates the entire RET proto-oncogene for germline mutations associated with Multiple Endocrine Neoplasia type 2A (MEN2A). It identifies genetic predisposition to medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
TEST-1912 RNASEL Gene Hereditary Prostate Cancer Type 1 Test This test evaluates the RNASEL gene for pathogenic variants associated with an increased risk of hereditary prostate cancer type 1.	Peripheral blood (whole blood) or buccal swab	3–4 Weeks from sample arrival	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RNASEL gene pathogenic variants", "RNASEL gene copy number variations"] Parameters [] Preparation [] Indications ["Strong family history of early-onset prostate cancer", "Known RNASEL mutations in the family"] Measurement technique Confirm with laboratory Codes LOINC: 80814-8 ICD-10: Z80.43 Clinical summary This test evaluates the RNASEL gene for pathogenic variants associated with an increased risk of hereditary prostate cancer type 1.
TEST-1938 SDHB Gene Pheochromocytoma Type 2 Genetic Test This test evaluates the SDHB gene for germline mutations associated with hereditary pheochromocytoma/paraganglioma type 2.	Whole Blood (Peripheral Blood) in EDTA Tube	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the SDHB gene", "Point mutations", "Small indels", "Large deletions/duplications"] Parameters [{"name": "SDHB Gene Mutation Analysis", "reference_range": "Negative (No pathogenic mutation detected)"}] Preparation ["No special dietary or medication preparation is required.", "Pre-test genetic counseling is strongly recommended."] Indications ["Individuals with clinical suspicion of hereditary pheochromocytoma/paraganglioma type 2", "Family members of individuals with known SDHB mutations", "Risk stratification for at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 79254-6 ICD-10: Z13.89 Clinical summary This test evaluates the SDHB gene for germline mutations associated with hereditary pheochromocytoma/paraganglioma type 2.
TEST-2055 SMAD4 Gene Juvenile Polyposis Syndrome Genetic Test This genetic test identifies pathogenic mutations within the SMAD4 gene associated with Juvenile Polyposis Syndrome.	Peripheral whole blood (3–5 mL EDTA) or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMAD4 gene pathogenic variants", "Hereditary predisposition to polyposis"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Juvenile Polyposis Syndrome", "Family history of JPS", "Personal history of multiple hamartomatous polyps"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q85.09 Clinical summary This genetic test identifies pathogenic mutations within the SMAD4 gene associated with Juvenile Polyposis Syndrome.
TEST-1886 VHL Gene (von Hippel-Lindau Syndrome) Genetic Test This test evaluates the VHL gene for germline mutations associated with von Hippel-Lindau syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VHL gene mutations", "Germline genetic variants"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of any medications or recent transfusions"] Indications ["Individuals with a personal or family history suggestive of von Hippel-Lindau syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q85.8 Clinical summary This test evaluates the VHL gene for germline mutations associated with von Hippel-Lindau syndrome.

Category overview

Hereditary Cancer: overview

Understanding your personal susceptibility to familial malignancies transforms anxiety into empowering, proactive control over your long-term health. Integrated into our specialized Genetics services, Hereditary Cancer testing evaluates your DNA for specific inherited mutations—such as BRCA1 or BRCA2—that significantly increase your risk of developing breast, ovarian, or colon cancers. Utilizing state-of-the-art diagnostic technology, this highly focused molecular profiling helps uncover hidden molecular risks, safely guiding your healthcare provider in tailoring highly personalized early screening protocols, preventative lifestyle adjustments, and life-saving prophylactic interventions. Trusted for oncological diagnostic excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical accuracy, and incredibly efficient turnaround times. Take an informed step toward cancer prevention—book your hereditary cancer testing in UAE, coordinate a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.